The neuroendocrine response to critical illness is a dynamic process.

[1]  T. Visser.  Thyroid Hormone Transporters , 2007, Hormone Research in Paediatrics.

[2]  G. Van den Berghe,et al.  Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  E. Kovacs,et al.  The impact of burn injury and ethanol on the cytokine network of the mouse hypothalamus: reproductive implications. , 2005, Cytokine.

[4]  F Bruyninckx,et al.  Insulin therapy protects the central and peripheral nervous system of intensive care patients , 2005, Neurology.

[5]  A. Hoitsma,et al.  Adrenocortical function: An indicator of severity of disease and survival in chronic critically ill patients , 2005, Intensive Care Medicine.

[6]  G. Van den Berghe,et al.  Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. , 2004, Current opinion in pharmacology.

[7]  Greet Van den Berghe,et al.  How does blood glucose control with insulin save lives in intensive care , 2004 .

[8]  P. Sandercock,et al.  Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial , 2004, The Lancet.

[9]  C. Bailey.  Is There Still a Place for Dopamine in the Modern Intensive Care Unit , 2004 .

[10]  Charles Natanson,et al.  Meta-Analysis: The Effect of Steroids on Survival and Shock during Sepsis Depends on the Dose , 2004, Annals of Internal Medicine.

[11]  Amir H Hamrahian,et al.  Measurements of serum free cortisol in critically ill patients. , 2004, The New England journal of medicine.

[12]  A. Comellas,et al.  Cortisol levels and mortality in severe sepsis , 2004, Clinical endocrinology.

[13]  G. Van den Berghe,et al.  Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. , 2004, Endocrinology.

[14]  D. Cummings,et al.  Growth hormone therapy in adults. , 2003, Annual review of medicine.

[15]  G. Van den Berghe,et al.  Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.

[16]  N. Tritos.  Corticosteroid insufficiency in acutely ill patients. , 2003, The New England journal of medicine.

[17]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[18]  P. Marik,et al.  Adrenal insufficiency in the critically ill: a new look at an old problem. , 2002, Chest.

[19]  G. Van den Berghe,et al.  The combined administration of GH‐releasing peptide‐2 (GHRP‐2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP‐2 alone , 2002, Clinical endocrinology.

[20]  G. Van den Berghe,et al.  A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.

[21]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[22]  G. Van den Berghe.  Dynamic neuroendocrine responses to critical illness. , 2002, Frontiers in neuroendocrinology.

[23]  G. V. Berghe,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[24]  D. Annane,et al.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.

[25]  D. Spratt.  Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated? , 2001, Best practice & research. Clinical endocrinology & metabolism.

[26]  A. Beishuizen,et al.  The hypothalamic-pituitary-adrenal response to critical illness. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[27]  R. Baxter,et al.  Changes in the IGF-IGFBP axis in critical illness. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[28]  N. Stathatos,et al.  The controversy of the treatment of critically ill patients with thyroid hormone. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[29]  K. Burchard,et al.  A review of the adrenal cortex and severe inflammation: quest of the "eucorticoid" state. , 2001, The Journal of trauma.

[30]  R. Wolfe,et al.  Testosterone administration in severe burns ameliorates muscle catabolism , 2001, Critical care medicine.

[31]  L. Thijs,et al.  Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma , 2001, Intensive Care Medicine.

[32]  V. Kyriazopoulou,et al.  Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. , 2001, The Journal of clinical endocrinology and metabolism.

[33]  G. Van den Berghe,et al.  Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. , 2001, The Journal of clinical endocrinology and metabolism.

[34]  P. Yen,et al.  Physiological and molecular basis of thyroid hormone action. , 2001, Physiological reviews.

[35]  A. Malhotra,et al.  Stress-induced hyperglycemia. , 2001, Critical care clinics.

[36]  G. V. Berghe,et al.  Novel insights into the neuroendocrinology of critical illness , 2000 .

[37]  D. Annane,et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.

[38]  G. Berghe.  New insights in the neuroendocrinology of critical illness , 2000 .

[39]  G. Van den Berghe,et al.  Increased mortality associated with growth hormone treatment in critically ill adults. , 2000, The New England journal of medicine.

[40]  R. Wolfe,et al.  Testosterone and muscle protein metabolism. , 2000, Mayo Clinic proceedings.

[41]  G. Van den Berghe,et al.  A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. , 2000, The Journal of clinical endocrinology and metabolism.

[42]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[43]  P. Carroll.  Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[44]  Steven M. Pincus,et al.  A sexually dimorphic pattern of growth hormone secretion in the elderly. , 1999, The Journal of clinical endocrinology and metabolism.

[45]  G. Chrousos,et al.  Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. , 1999, The Journal of clinical endocrinology and metabolism.

[46]  R. Demling,et al.  Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. , 1999, Burns : journal of the International Society for Burn Injuries.

[47]  G. Van den Berghe,et al.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.

[48]  J. Ketelslegers,et al.  GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. , 1999, The American journal of physiology.

[49]  L. J. Groot,et al.  Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .

[50]  O. Ljungqvist,et al.  Insulin resistance: a marker of surgical stress. , 1999, Current opinion in clinical nutrition and metabolic care.

[51]  R. Baxter,et al.  Thrity-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients , 1998 .

[52]  G. Van den Berghe,et al.  Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. , 1998, The Journal of clinical endocrinology and metabolism.

[53]  G. Van den Berghe,et al.  Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. , 1998, The Journal of clinical endocrinology and metabolism.

[54]  R. Baxter,et al.  Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[55]  I. Chaudry,et al.  Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. , 1998, The American journal of physiology.

[56]  E. Fliers,et al.  Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.

[57]  G. Van den Berghe,et al.  Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues , 1997, Clinical endocrinology.

[58]  G. Van den Berghe,et al.  The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. , 1997, The Journal of clinical endocrinology and metabolism.

[59]  J. Wernerman,et al.  Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. , 1997, The Journal of clinical endocrinology and metabolism.

[60]  C. Gorman,et al.  Euthyroid sick syndrome: an overview. , 1997, Thyroid : official journal of the American Thyroid Association.

[61]  O. Kirton,et al.  Adrenal insufficiency in the surgical intensive care unit patient. , 1997, The Journal of trauma.

[62]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[63]  D. Cook,et al.  Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. , 1995, Critical care medicine.

[64]  R. Lefering,et al.  Steroid controversy in sepsis and septic shock: a meta-analysis. , 1995, Critical care medicine.

[65]  T. van der Poll,et al.  Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. , 1995, The Journal of clinical endocrinology and metabolism.

[66]  G. Van den Berghe,et al.  DOPAMINE AND THE EUTHYROID SICK SYNDROME IN CRITICAL ILLNESS , 1995 .

[67]  P. Rothwell,et al.  Prediction of outcome in intensive care patients using endocrine parameters. , 1995, Critical care medicine.

[68]  F. Zegher,et al.  Dopamine and the sick euthyroid syndrome in critical illness , 1994, Clinical endocrinology.

[69]  F. Zegher,et al.  Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine , 1994, Clinical endocrinology.

[70]  T. R. Hennessy,et al.  Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. , 1994, The American journal of physiology.

[71]  H. van Toor,et al.  Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. , 1993, The Journal of clinical endocrinology and metabolism.

[72]  L. Thijs,et al.  Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient. , 1992, The Netherlands journal of medicine.

[73]  G. Reisz,et al.  Effects of dopamine on T‐lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients , 1992, Critical care medicine.

[74]  David Handelsman,et al.  Circulating immunoreactive inhibin and testosterone levels in men with critical illness , 1992, Clinical endocrinology.

[75]  J. Miell,et al.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐I , 1991, Clinical endocrinology.

[76]  P. Rothwell,et al.  Cortisol response to corticotropin and survival in septic shock , 1991, The Lancet.

[77]  H. Guo,et al.  Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis. , 1990, Endocrinology.

[78]  W. Sibbald,et al.  A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. , 1990, The Journal of clinical endocrinology and metabolism.

[79]  W. Wiersinga,et al.  Decreased nocturnal surge of thyrotropin in nonthyroidal illness. , 1990, The Journal of clinical endocrinology and metabolism.

[80]  A. Pinchera,et al.  Lack of nocturnal serum thyrotropin surge after surgery. , 1990, The Journal of clinical endocrinology and metabolism.

[81]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[82]  W. Vale,et al.  In the rat, interleukin-1 alpha acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. , 1989, Endocrinology.

[83]  D. Russell.  New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. , 1989, Trends in pharmacological sciences.

[84]  P. Stein,et al.  Hormone binding globulins undergo serpin conformational change in inflammation , 1988, Nature.

[85]  J. Holaday,et al.  Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. , 1988, Science.

[86]  A. Beddoe,et al.  Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. , 1987, The Journal of trauma.

[87]  Lothar Späth,et al.  A New Look at an Old Problem , 1986 .

[88]  N. Ben-Jonathan.  Dopamine: a prolactin-inhibiting hormone. , 1985, Endocrine reviews.

[89]  L. Matrisian,et al.  Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. , 1985, Journal of immunology.

[90]  J. Mead,et al.  Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses. , 1985, The Journal of clinical endocrinology and metabolism.

[91]  R. T. Rada,et al.  Pituitary-testicular axis dysfunction in burned men. , 1985, The Journal of clinical endocrinology and metabolism.

[92]  R. Hamill,et al.  Transient hypogonadotropic hypogonadism caused by critical illness. , 1985, The Journal of clinical endocrinology and metabolism.

[93]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[94]  F. Momany,et al.  On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. , 1984, Endocrinology.

[95]  W. Vale,et al.  Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin , 1983, Nature.

[96]  J. Mckee,et al.  SERUM CORTISOL LEVELS IN SEVERELY STRESSED PATIENTS , 1982, The Lancet.

[97]  C. Stanley,et al.  Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. , 1979, The New England journal of medicine.

[98]  V. Chan,et al.  EFFECT OF ACUTE MYOCARDIAL INFARCTION ON PITUITARY‐TESTICULAR FUNCTION , 1978, Clinical endocrinology.

[99]  C. Wang,et al.  EFFECT OF SURGICAL STRESS ON PITUITARY‐TESTICULAR FUNCTION , 1978, Clinical endocrinology.

[100]  J. Meakins,et al.  Delayed Hypersensitivity: Indicator of Acquired Failure of Host Defenses in Sepsis and Trauma , 1977, Annals of surgery.

[101]  K. O. Lewis,et al.  ENZYME INDUCTION AND ALCOHOLISM , 1976, The Lancet.

[102]  T. Cicero,et al.  Function of the male sex organs in heroin and methadone users. , 1975, The New England journal of medicine.

[103]  Andrée Tixier-Vidal,et al.  The anterior pituitary , 1975 .

[104]  P. Beck‐Peccoz,et al.  Reduced Plasma Thyrotropin Response to Thyrotropin Releasing Hormone After Dexamethasone Administration in Normal Subjects , 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[105]  G. L. Noel,et al.  Human prolactin and growth hormone release during surgery and other conditions of stress. , 1972, The Journal of clinical endocrinology and metabolism.

[106]  A. Jost.  [The anterior pituitary of the fetus]. , 1962, Biologie medicale.